In such case, diagnosis of de novo rhabdomyosarcoma is basically a function of extensiveness of tissue sampling except for alveolar rhabdomyosarcoma for which molecular analysis for PAX3/7-FHKR translocation can be used to confirm the diagnosis. This evidence concerns the gene PAX3 and alveolar rhabdomyosarcoma.